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INTRODUCTION
Cochlear implantation has become the standard treatment for pa-
tients with severe to profound sensorineural hearing loss. Moreover,
cochlear implantation has been shown to be safe in young chil-
dren, and is now commonly performed in children younger than
2 years of age (1, 2).
However, revision cochlear implantation are uncommon, and
many surgeons are not familiar with revision operations. Never-
theless, revision operation is inevitable in some conditions such
as device failure, misplaced electrode, and device migration or
extrusion. Wound problems, foreign body reaction, mastoiditis,
meningitis, cholesteatoma, and device upgrades may also lead
to the need for a revision operation (3-6). Currently, surgeons
are being required to conduct more revision operations, because
the number of implanted patients is increasing.
During revision surgery, the surgeon should take care not to
damage or mobilize the previously implanted device, especially
the active electrodes. There are also some restrictions concerning
the use of electrocautery. When reimplantation of an active elec-
trode is necessary, the situation becomes more complicated, as
removing the initial electrode and inserting a new one may cause
intracochlear damage and result in a reduction in speech perfor-
mance (7, 8). Moreover, the surgeon may be unable to fully rein-
sert the new electrodes through the previous cochleostomy site
(7). Although revision cochlear implantation surgery raises
many questions, little is known about its outcomes. 
The aims of this study were to evaluate the reasons for reim-
plantation and the outcomes in patients that had previously
undergone cochlear implantation. We placed special emphasis
on device failure because this is the most common reason for
revision surgery (7-9), and it may carry a higher risk of intra-
cochlear damage following reimplantation.
MATERIALS AND METHODS
The medical records of 720 patients that had undergone co-
chlear implantation between March 1990 and April 2007 were
reviewed retrospectively. Patients ages ranged from 12 months
to 83 years, and averaged 13.6 years. Of these 720 patients, 30
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Objectives. The aim of this study was to evaluate the clinical features of cochlear reimplantation due to device failure.
Methods. The medical records of 30 patients who had undergone a revision cochlear implantation were retrospectively
reviewed. Causes of revision operations, number of electrode channels inserted, and postoperative speech perfor-
mances were analyzed.
Results. Device failure (N=12, 38.7%) and hematoma (N=3, 9.6%) were the two most common reasons for revision
surgery. In patients with device failure, the number of electrode channels reinserted was equal to, or more than
the number of channels inserted during initial implantation. Speech performance scores remained the same, or
improved after reimplantation in patients with device failure.
Conclusion. Device failure was the most common cause of revision operation in patients with cochlear implanttion.
Contrary to expectation, new electrodes were fully inserted without difficulty in all reimplantation cases.
Intracochlear damage due to reimplantation appeared to be clinically insignificant.
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Original Article(4.2%) underwent a revision operation. Two of the 30 had ini-
tially received their implants at another institute, while the
remaining 28 (3.9%) had undergone initial implantation at the
same institute. 
There were 12 patients who underwent reimplantation due to
device failure. The age of the 12 patients with device failure ranged
from 24 months to 30.2 years (average 9.2 years) at reimplantation.
Five male and seven female patients were included. All of the
patients with device failure who were included in this study had
hard failure; there were no soft failure cases. Device failure was
confirmed by voltage growth measurements and integrity testing.
If a patient presented with no sound perception, the patient was
sent to an audiologist for voltage growth measurements by imped-
ance test. If there was no detectable voltage growth, device integri-
ty testing was performed by the manufacturer for confirmation.
Device failure was confirmed if there was no response in both the
voltage growth measurements and integrity testing.
In reimplantation cases due to device failure, we determined
the device type first implanted, with rates of device failure being
assessed by the manufacturer. In addition, the number of chan-
nels inserted through the cochlea during initial operation was
compared to those inserted at reimplantation, in each patient.
Speech perception performance was compared before and after
reimplantation in cases of device failure, as determined by open-
set monosyllabic word and open-set sentence tests. Phonemically
balanced words were used for the monosyllabic word test, and
Korean version Central Institute for the Deaf (K-CID) score was
used for the sentence test. Latest speech perception performance
data obtained using initial cochlear implants were compared with
latest perception performance data after reimplantation. Changes
in speech perception performance were classified as improved,
poorer, or no change. An increase in speech perception perfor-
mance score of greater than 5% was defined as improved. A
decrease in speech perception performance score of greater than
5% was defined as poorer, and no change was defined as a change
in speech perception performance score of less than 5%.
Statistical analysis was performed using the SPSS software
(SPSS Inc., Chicago, IL, USA). The Chi-square test was used to
analyze differences between manufacturers with respect to device
failure rates. P values of <0.05 were considered statistically sig-
nificant, and all tests were two-tailed.
RESULTS
Table 1 presents a summary of the reasons for revision operations.
The most common cause of revision operation was device failure
(38.7%), and all patients with device failure underwent reimplan-
tation soon after failure had been detected; time lapsed between
the two surgeries ranged from 2 months to 9 years 8 months (mean,
38.2 months). The failed devices included 8 (1.4%) Nucleus de-
vices, 3 (2.6%) Clarion devices, and 1 (2.2%) Med-El device
(Table 2). No significant difference was found between manu-
facturers in terms of the incidence of device failure (P=0.42). In
device failure patients, we tried to use the most updated model
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Cause of revision operation No (%)
Table 1. Causes of revision cochlear implantation
*One patient had ground electrode exposure in the mastoid cavity and
device failure. 
A: number of channels inserted during operation, B: total number of chan-
nels in the active electrode.
Device failure* 12 (38.7)
Misplaced active electrode 2 (6.5)
Hematoma 3 (9.6)
Wound infection 2 (6.5)
Flap necrosis and/or device extrusion 2 (6.5)
Facial nerve twitching 2 (6.5)
Ground electrode exposure in mastoid*  2 (6.5)
Magnet displaced 2 (6.5)
Incomplete insertion of the electrode  1 (3.2)
Immediate facial nerve paralysis 1 (3.2)
External auditory canal keratoma  1 (3.2)
Irritative suture material 1 (3.2)
Total 31
Device type No of device
failure (%)
Table 2. Rate of device failure by manufacturer
Nucleus (N=561) Nucleus CI22M 4
Nucleus CI24M 2
Nucleus CI24R (CS) 2
Total 8 (1.4)
Advanced bionics  Clarion I 2
(N=114) Clarion HighRes 90K 1
Total 3 (2.6)
MED-EL (N=45) MED-EL Combi 40+ 1
Total 1 (2.2)
First implantation (A/B) Reimplantation (A/B)
Table 3. Number of channels inserted during first and second im-
plantations in patients with device failure
Patient 1 22/22 = 22/22
Patient 2 22/22 = 22/22
Patient 3 21/22 < 22/22
Patient 4 22/22 = 22/22
Patient 5 16/16 = 16/16
Patient 6 22/22 = 22/22
Patient 7 22/22 = 22/22
Patient 8 22/22 = 22/22
Patient 9 16/16 = 16/16
Patient 10 16/16 = 16/16
Patient 11 16/16 = 16/16
Patient 12 12/12 = 12/12of the same manufacturer’s device that was used in the initial
implantation. We did not select the device for reimplantation
by the size of electrode array. The electrode was incompletely
inserted in one patient (Patient 3, 21 electrodes out of 22) at
initial implantation. However, electrodes were fully inserted in
the other eleven patients (Table 3). At reimplantation, all elec-
trodes were fully inserted in all patients. Table 4 shows result of
impedance test after reimplantation in device failure patients.
In device failure patients, speech perception performances before
and after reimplantation are summarized in Table 5. In the phone-
mically balanced word test, eight patients (66.6%) demonstrat-
ed improved speech perception performance after reimplanta-
tion, and four patients (33.3%) demonstrated no change; no patient
demonstrated a poorer performance. In the K-CID sentences test,
seven patients (58.3%) showed improved speech perception per-
formance after reimplantation, and five patients (41.6%) showed
no change. Again, no patient demonstrated poorer scores after
revision operation. Fig. 1, 2 demonstrate individual speech per-
ception performance results in patients with device failure, after
reimplantation.
DISCUSSION
The number of patients with cochlear implants that require revi-
sion surgery is gradually increasing (9-12). Currently, a revision
rate of 5% appears to be a reasonable estimate (9, 13). In the
present study, the revision rate was 4.2%, which concurs with
previous reports. However, in view of the fact that 3,154 cochlear
implantations were performed in South Korea before 2006, it is
expected that around 100 of these patients have either undergone
or will undergo a revision operation.
Device failure has been reported to occur at an incidence of
3.2-4.9% (12, 14). A multicenter study involving several Euro-
pean cochlear implant centers reported a device failure rate of
3.79% (15), while the present study showed it to be 1.7%. Howe-
ver, the reasons for this lower failure rate are not apparent. In
terms of failure rates among manufacturers, previous studies
have reported higher rates for Clarion devices than for Nucleus
or Med-El devices (16-18). However, in the present study, fail-
ure rates were comparable.
When considering reimplantation, one concern is that inser-
tion of the new electrode to the same depth may not be possi-
ble. Surgeons are concerned that the intracochlear tunnel may
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Pt. 1 Pt. 2 Pt. 3 Pt. 6 Pt. 7 Pt. 8 Pt. 10 Pt. 11 Pt. 12 Channel No
Table 4. Impedance test after reimplantation in patients with device failure
Pt.: Patient.
Impedance test results were not available in Pts 4, 5, or 9.
1 5.4 14 12.76 8.8 9.3 8.41 7.46 5.1 10.04
2 6.25 15.8 12.55 12.3 12 8.03 7.68 6.7 9.08
3 6.29 7 12.76 10.4 10.1 8.07 7.50 5.3 9.26
4 4.55 6.4 10.53 7.5 9.6 8.03 8.41 6.4 7.88
5 4.58 5.4 12.35 10.8 10.9 8.64 9.77 8.3 7.58
6 2.57 6.4 11.34 10.6 8.3 8.45 7.95 8 7.52
7 2.27 6.4 8.71 9.7 9.6 8.07 8.63 6.3 8.66
8 1.99 13.1 11.14 12.3 9.9 8.60 5.23 7.7 8.30
9 2.00 11.8 10.12 12.6 10.9 9.41 4.32 7.7 7.88
10 2.00 11.3 10.93 7.7 9.9 11.14 5.00 4 7.40
11 1.99 15.6 10.33 9.5 11 10.56 5.23 6.4 6.38
12 3.43 12.9 11.34 12.6 6.4 8.93 5.68 6.8 7.58
13 5.97 13.7 10.93 12.1 5.6 8.07 6.78 7.7
14 7.39 14.2 9.72 10.1 7.5 8.45 6.55 5.9
15 7.44 10.5 11.34 12.8 11.5 8.26 5.91 8.1
16 4.26 10.5 6.40 10.8 9.3 9.03 7.04 9.9
17 5.72 7.90 8.64 7.50
18 4.06 9.31 7.49 8.18
19 3.41 3.44 7.49 7.27
20 4.58 4.46 7.11 7.73
21 3.69 4.46 8.64 6.10
22 3.98 8.30 9.60 8.59
Phoneme balanced
word test (%)
K-CID sentences
test (%)
Table 5. Outcomes in speech perception performance
Improved 8 (66.6) 7 (58.3)
No change 4 (33.3) 5 (41.6)
Poorer 0 (0.0) 0 (0.0)collapse after removing the initial electrode. In fact, one article
reported that insertion depth and channel number are signifi-
cantly lower for second implantations (18). However, other stud-
ies found that insertion depth and active channel number remain
unchanged after reimplantation (5, 9, 14). In the present study,
it was found that the entire length of all electrodes was able to
be reinserted in all patients. 
Sometimes we observed new bone formation around the pos-
terior tympanotomy site. In such cases, we performed further
drilling to remove new bone formation. There was no difficulty
in this endeavor, such as resistance to insertion. We did not need
to perform further drilling in the cochleostomy site.
According to histological studies on cochlea changes, a fibrous
capsule forms around electrodes after insertion (19) and appears
to maintain the lumen of the cochleostomy after electrode re-
moval. However, it is not known how long this lumen remains,
and, when removing the receiver stimulator, the electrode should
be left in situ as a stylet, to maintain the intracochlear lumen until
reimplantation, if immediate reimplantation is not possible.
Although hematoma, wound infections, flap problems, and
magnet displacement may lead to the need for revision opera-
tions, device failure presents a different problems, as it requires
intracochlear electrode manipulation during the revision opera-
tion. In the present study, we analyzed the speech perception
performances of the patients that had experienced device fail-
ure, because these patients are at higher risk of intracochlear
damage. 
If intracochlear structures are damaged during reimplantation,
speech perception performance is unlikely to improve despite
the presence of a functioning device. In several animal studies,
reimplantation has been definitively associated with injury of
the organ of corti, stria vascularis, spiral ligament, or spiral gan-
glion cells (20, 21), and some human studies have reported
poorer speech perception after reimplantation (7, 8). Thus, if
significant intracochlear damage and no improvement in speech
perception performance is expected, it might be advisable not
to perform reimplantation based on considerations of the costs
of the device and medical services and the risk of complications.
However, recent studies have found that reimplantation may
cause little or no damage to inner cochlear structures (22), and
the majority of authors have reported that speech perception
performance improves after reimplantation (5, 9, 10, 12, 14,
23). In our series, speech perception performances remained
the same or improved after reimplantation, and no patient expe-
rienced deterioration. Nevertheless, patients 1, 2, and 3 require
further explanation, as speech perception performance was 0 in
these patients after reimplantation. Patients 1 and 2 had substan-
tial developmental delays, which may have influenced speech
perception outcome, whereas patient 3 was lost to follow-up 6
months postoperatively. Thus, it is not clear whether poor speech
perception performance after reimplantation was due to intra-
cochlear damage or some other reason in these patients. However,
the eight patients whose speech perception performances im-
proved demonstrated that intracochlear damage might not be
clinically significant. In general, an improvement in speech per-
ception performance may be expected, and reimplantation should
therefore be recommended when device failure is documented. 
It should be noted that electrodes removed from our device
failure patients were not all modulus hugging type electrodes.
During initial implantation in our patients, a conventional elec-
trode was usually located on the lateral side of the scala tympa-
ni, which reduces the possibility of spiral ganglion cell damage
during reimplantation. However, currently available electrodes
are usually of the modulus hugging type, and because this elec-
trode type wraps the weak central core of the cochlea, removing
it may cause significant damage to the cochlea. Further studies
on reimplantation treatment results in patients who have under-
gone an initial implantation with a modulus hugging type elec-
trode, are necessary.
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Fig. 1. Speech perception performance of patients by the Phoneme
balanced word test: eight patients (66.6%) demonstrated improved
speech perception performance after reimplantation, and 4 patients
(33.3%) demonstrated little or no change.
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Fig. 2. Speech perception performance of patients by the KCID-sen-
tences test: seven patients (58.3%) showed improved speech per-
ception performance after reimplantation, and 5 (41.6%) showed lit-
tle or no change.
K-CID test: Korean version of the central institute for the deaf test.14 Clinical and Experimental Otorhinolaryngology  Vol. 1, No. 1: 10-14, March 2008
CONCLUSIONS
Device failure was found to be the most common cause of revi-
sion operation in our patients. Full insertion of all channels can
be expected during reimplantation, and speech perception per-
formance should improve or remain stable, indicating that intra-
cochlear damage due to reimplantation is clinically insignificant. 
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